January 2018 DAIDS Council-Approved Concepts

Concepts represent early planning stages for program announcements, requests for applications, or solicitations for Council's input. If NIAID publishes an initiative from one of these concepts, we link to it below. To find initiatives, go to Opportunities & Announcements.

NB: Council approval does not guarantee that a concept will become an initiative.

Table of Contents

Fiscal Year 2021 Concepts

Fiscal Year 2019 Concept

Fiscal Year 2019 Small Business Innovation Research (SBIR) Contract Solicitation Topics

HIV Prevention Clinical Trials Leadership and Operations Center (Clinical Trial Required)

For the published request for applications, see the January 24, 2019 Guide announcement HIV Prevention Clinical Trials Network Leadership and Operations Center (UM1, Clinical Trial Required).

HIV Vaccines Clinical Trials Leadership and Operations Center (Clinical Trial Required)

For the published request for applications, see the January 24, 2019 Guide announcement HIV Vaccines Clinical Trials Network Leadership and Operations Center (UM1, Clinical Trial Required).

HIV/AIDS Adult Therapeutics Clinical Trials Leadership and Operations Center (Clinical Trial Required)

For the published request for applications, see the January 24, 2019 Guide announcement HIV/AIDS Adult Therapeutics Clinical Trials Network Leadership and Operations Center (UM1, Clinical Trial Required).

HIV/AIDS Clinical Trials Laboratory Centers (Clinical Trial Required)

For the published request for applications, see the January 24, 2019 Guide announcement HIV/AIDS Clinical Trials Networks Laboratory Centers (UM1, Clinical Trial Required).

HIV/AIDS Clinical Trials Statistical and Data Management Centers (Clinical Trial Required)

For the published request for applications, see the January 24, 2019 Guide announcement HIV/AIDS Clinical Trials Networks Statistical and Data Management Centers (SDMC) (UM1, Clinical Trial Required).

HIV/AIDS Clinical Trials Units (Clinical Trial Required)

For the published request for applications, see the May 1, 2019 Guide announcement HIV/AIDS Clinical Trials Units (UM1 Clinical Trial Required).

HIV/AIDS Maternal, Adolescent, and Pediatric Health Therapeutics Clinical Trials Leadership and Operations Center (Clinical Trial Required)

For the published request for applications, see the January 24, 2019 Guide announcement HIV/AIDS Maternal, Adolescent and Pediatric Therapeutics Clinical Trials Network Leadership and Operations Center (UM1, Clinical Trial Required).

Novel Biomarkers for the Development of HIV Incidence Assays With Improved Specificity

For the published requests for applications, see the April 11, 2018 Guide announcements, Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional) and Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trial Not Allowed).

In Vivo Targeted Degradation of HIV Proteins

For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).

Particle-Based Delivery of HIV Env Immunogens

For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).

Co-Delivery and Formulation of Adjuvants for HIV Vaccines

For the published request for proposals, see the July 18, 2018 Solicitation of NIH and CDC for Small Business Innovation Research (SBIR) Contract Proposals (PHS 2019-1).

Content last reviewed on May 2, 2019